...
首页> 外文期刊>Journal of biomedical materials research. Part B, Applied biomaterials. >Electrospun polyethersolfone nanofibrous membrane as novel platform for protein immobilization in microfluidic systems
【24h】

Electrospun polyethersolfone nanofibrous membrane as novel platform for protein immobilization in microfluidic systems

机译:电纺聚醚族纳面纤维膜作为微流体系统中蛋白质固定性的新平台

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract In the present study, the feasibility of electrospun polyethersolfone (PES) nanofibrous membrane as the solid substrate for microfluidic based immunoassays to enhance the density of immobilized antibody on the surface of membrane was assessed. Conversely, the efficacy of antibody immobilization was compared by two different strategies as 1‐Ethyl‐3‐(3‐dimethylaminopropyl)‐carbodiimide (EDC)/N‐Hydroxysuccinimide ( NHS ) coupling chemistry and hydrophobic interaction. Compared to conventional immunoassays carried out in plates or gels, microfluidic based immunoassays grant a lot of advantages such as a consumption of little samples and reagents, shorter analysis time, and higher efficiency. Therefore, microfluidic immunoassays can be efficiently used as a point‐of‐care device in medical diagnosis. Surprisingly, we found the increase of specific surface areas of the microfluidic channels improve density of immobilized proteins and leads to higher signal strength. Anti‐staphylococcus enterotoxin B (anti‐SEB) was used as an analyte model to demonstrate the utility of our proposed platform. Fluorescent microscopy, Fourier transform infrared spectroscopic (FTIR), gas adsorption, contact angle, X‐ray photoelectron spectroscopy (XPS), scanning electron microscopy (SEM), Uv‐Vis spectrophotometer and atomic force microscopy (AFM) techniques were used to assess the efficacy of antibody immobilization on the surface. To understand dominant mechanism of protein immobilization, zeta potential measurement was also carried out and it was found electrostatic attraction play significant role in antibody immobilization running into micro‐ channels containing through EDC/NHS. Moreover, incorporation of nanofibrous membrane causes significant improvement in the signal detection of microfluidic based immunoassay. ? 2017 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 106B: 1108–1120, 2018.
机译:摘要在本研究中,评估了电纺聚乙烯族(PES)纳米纤维(PES)作为用于微流体基的免疫基质的固体基质的可行性,以增强膜表面上的固定抗体密度。相反,通过两种不同的策略作为1-乙基-3-(3-二甲基氨基丙基) - 碳二亚胺(EDC)/ N-羟基琥珀酰亚胺(NHS)偶联化学和疏水相互作用将抗体固定化的功效进行了比较。与板或凝胶中的常规免疫测定相比,基于微流体的免疫测定授予大量优点,例如小样品和试剂的消耗,更短的分析时间和更高的效率。因此,微流体免疫测定可以有效地用作医学诊断的护理点装置。令人惊讶的是,我们发现微流体通道的比表面积的增加提高了固定蛋白质的密度并导致更高的信号强度。抗葡萄球菌肠毒素B(抗SEB)用作分析物模型,以证明我们所提出的平台的效用。荧光显微镜,傅里叶变换红外光谱(FTIR),气体吸附,接触角,X射线光电子能谱(XPS),扫描电子显微镜(SEM),UV-Vis分光光度计和原子力显微镜(AFM)技术用于评估抗体固定在表面上的疗效。为了了解蛋白质固定化的显性机制,还进行了Zeta电位测量,并且发现静电吸引在抗体固定中发挥着显着作用,该抗体在含有通过EDC / NHS的微通道中的抗体固定化。此外,纳米纤维膜的掺入导致微流体的免疫测定的信号检测显着改善。还2017 Wiley期刊,Inc。J生物保证师AP:Appl Biomater,106B:1108-1120,2018。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号